These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 34629888)

  • 1. Analysis of Very Important Pharmacogenomics Variants in the Chinese Lahu Population.
    Cheng Y; Li Q; Yang X; Ding H; Chen W; Dai R; Zhang C
    Pharmgenomics Pers Med; 2021; 14():1275-1289. PubMed ID: 34629888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms of pharmacogenomic VIP variants in the Lahu population from Yunnan Province.
    Dou X; Yang S; Zhang W; Meng W; Zhao W; Hao J; Hu X; Guo L; Jin T
    Gene; 2022 Nov; 844():146825. PubMed ID: 35995116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The population genetics of pharmacogenomics VIP variants in the Sherpa population.
    Wang L; Ren Y; Shi X; Yuan D; Liu K; Geng T; Li G; Kang L; Jin TB
    Drug Metab Pharmacokinet; 2016 Feb; 31(1):82-89. PubMed ID: 26825850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of pharmacogenomic VIP variants in the Dai population from Yunnan province.
    Cheng Y; Dai R; Chen W; Li Q; Zhang C; Yang T
    Mol Genet Genomic Med; 2020 Jul; 8(7):e1231. PubMed ID: 32347657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms analysis of pharmacogenomic VIP variants in Bai ethnic group from China.
    Chen W; Ding H; Cheng Y; Li Q; Dai R; Yang X; Zhang C
    Mol Genet Genomic Med; 2019 Sep; 7(9):e884. PubMed ID: 31361092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms of pharmacogenomic VIP variants in the Kyrgyz population from northwest China.
    Yunus Z; Liu L; Wang H; Zhang L; Li X; Geng T; Kang L; Jin T; Chen C
    Gene; 2013 Oct; 529(1):88-93. PubMed ID: 23954225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms study of pharmacogenomic VIP variants in Han ethnic of China's Shaanxi province.
    Jin T; Zhao R; Shi X; He N; He X; Ouyang Y; Wang H; Wang B; Kang L; Yuan D
    Environ Toxicol Pharmacol; 2016 Sep; 46():27-35. PubMed ID: 27414743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms of pharmacogenomic VIP variants in the lhoba population of southwest China.
    He Y; Yang H; Geng T; Feng T; Yuan D; Kang L; Luo M; Jin T
    Int J Clin Exp Pathol; 2015; 8(10):13293-303. PubMed ID: 26722533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The landscape of very important pharmacogenes variants and potential clinical relevance in the Chinese Jingpo population: a comparative study with worldwide populations.
    Ma X; Li Y; Zang X; Guo J; Zhou W; Han J; Liang J; Wan P; Yang H; Jin T
    Cancer Chemother Pharmacol; 2024 May; 93(5):481-496. PubMed ID: 38300251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of pharmacogenomic VIP variants in the Wa population from Yunnan Province of China.
    Li D; Peng L; Xing S; He C; Jin T
    BMC Genom Data; 2021 Nov; 22(1):51. PubMed ID: 34798807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of pharmacogenomic VIP variants in the Yi population from China.
    Yan M; Li D; Zhao G; Li J; Niu F; Li B; Chen P; Jin T
    Gene; 2018 Mar; 648():54-62. PubMed ID: 29337087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analysis of pharmacogenomic VIP variants in the Blang population from Yunnan Province of China.
    Zhang C; Guo W; Cheng Y; Li Q; Yang X; Dai R; Zhu L; Chen W
    Mol Genet Genomic Med; 2019 May; 7(5):e574. PubMed ID: 30955239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetic variability of MDR1 C3435T polymorphisms in four Southern Chinese populations.
    Dong Q; Xu B; Tan Y; Liu Z; Tian L; Zhang B; Lin CK; Kung HF; Sung JJ; He ML
    Biomed Pharmacother; 2009 Nov; 63(9):658-62. PubMed ID: 18926661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethnic variability in the allelic distribution of pharmacogenes between Korean and other populations.
    Kim IW; Kim KI; Chang HJ; Yeon B; Bang SJ; Park T; Kwon JS; Kim S; Oh JM
    Pharmacogenet Genomics; 2012 Dec; 22(12):829-36. PubMed ID: 22955668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of pharmacogenomic VIP variants in the Mongol of Northwestern China.
    Jin T; Shi X; Wang L; Wang H; Feng T; Kang L
    BMC Genet; 2016 May; 17(1):70. PubMed ID: 27233804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of pharmacogenomic very important pharmacogenomic variants:
    Meng W; Zhang W; Yang S; Dou X; Liu Y; Li H; Liu J; Jin T; Li B
    Per Med; 2022 Sep; 19(5):403-410. PubMed ID: 35801384
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic polymorphisms in very important pharmacogenomic variants in the Zhuang ethnic group of Southwestern China: A cohort study in the Zhuang population.
    Li J; Guo C; Yan M; Niu F; Chen P; Li B; Jin T
    Medicine (Baltimore); 2018 Apr; 97(17):e0559. PubMed ID: 29703042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very important pharmacogenetic variants landscape and potential clinical relevance in the Zhuang population from Yunnan province.
    Li Y; Chang Y; Yan Y; Ma X; Zhou W; Zhang H; Guo J; Wei J; Jin T
    Sci Rep; 2024 Mar; 14(1):7495. PubMed ID: 38553524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of pharmacogenomic VIP variants in the Hui population from Ningxia Province of China.
    Zhou W; Guo J; Li Y; Ma X; Yang S; Wei J; Zhang H; Zhang S; Jin T
    Funct Integr Genomics; 2023 Mar; 23(2):85. PubMed ID: 36930384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Polymorphisms Analysis of Pharmacogenomic VIP Variants in Miao Ethnic Group of Southwest China.
    Jin T; Aikemu A; Zhang M; Geng T; Feng T; Kang L; Luo ML
    Med Sci Monit; 2015 Dec; 21():3769-76. PubMed ID: 26632549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.